Scaling Beyond the eSTAR Chasm

Cross the eSTAR Chasm - Scale Submissions with Essenvia AI

Summary

01
FDA eSTAR Initiative Streamlines 510(k) Submissions

Launched in 2023, eSTAR replaced the error-prone eCopy process with an interactive PDF template that improves structure, clarity, and completeness. It integrates FDA guidance, offers validation checks, and has reduced technical screening errors from 20.5% to 5.4% (per 2025 MDUFA V data).

02
Challenges Remain Despite eSTAR's Success

MedTech regulatory teams face hurdles with collaboration, traceability, training burdens, and form performance issues. A 2023 survey showed 78% of respondents had concerns, particularly around lack of access control and update delays.

03
Essenvia’s AI-Powered eSTAR Portal Solves Critical Bottlenecks

Essenvia’s patented online eSTAR platform enables team collaboration where users can work on different sections simultaneously, direct PLM/eQMS integrations, automatic version updates, and error reduction—accelerating submission time by an average of 19 weeks.

04
Strategic Value for Global and US Market Entry

As eSTAR becomes mandatory for more submission types and expands internationally (e.g., Health Canada), automation becomes essential. AI-driven submission processes offer a competitive edge by slashing time to market and freeing RA teams for strategic work.

Image

Essenvia allows collaborative authoring and simultaneous users on FDA eSTAR submissions

Transitioning your 510(k) submissions to eSTAR has never been easier with Essenvia’s eSTAR submission builder.

Easily adapt to eSTAR

It’s easy and intuitive to use Essenvia’s eSTAR builder. In no time, cross-functional teams within your organization will find it extremely efficient and be an invaluable tool for regulatory and submissions functions.

Here’s just a taste of what Essenvia can do for your company:

‣ Provides an easy digital walkthrough of every step
‣ Map your custom templates to eSTAR
‣ Edit your eSTAR live with multiple stakeholders
‣ Map and auto-update all attachments
‣ Gives a one-click preview of the native eSTAR file

Trusted by Regulatory Affairs Teams Globally

I’ve seen a lot of so-called AI softwares but very few are actually AI, and this [Essenvia] is the real deal.

Regulatory VP · Top 15 Medtech

Quote Icon

Essenvia RIM is easy to use and fast to setup. We save at least 20% of our time with using Essenvia's capabilities. Our experience with other RIMS tools made day-to-day operations more complex and did not fit into our workflows

Sejal Chitre

Sejal Chitre

Director Global Regulatory Affairs

Quote Icon

Essenvia greatly shortens the time to submission. It saved us countless hours in managing files, edits and even major updates at the last minute for very complex submissions. We can’t live without using the platform now.

John Landsdown

John Landsdown

Director of Quality, Regulatory Affairs & Compliance

Quote Icon

We completed and successfully submitted our first FDA eSTAR submission using Essenvia. Thanks to this Platform our team was able to work together in one single place at any time to author, edit, and review the submission.

Marta Stepien

Marta Stepien

VP of Clinical, Regulatory and Quality Affairs

I’ve seen a lot of so-called AI softwares but very few are actually AI, and this [Essenvia] is the real deal.

Regulatory VP · Top 15 Medtech

Quote Icon

Essenvia RIM is easy to use and fast to setup. We save at least 20% of our time with using Essenvia's capabilities. Our experience with other RIMS tools made day-to-day operations more complex and did not fit into our workflows

Sejal Chitre

Sejal Chitre

Director Global Regulatory Affairs

Quote Icon

Essenvia greatly shortens the time to submission. It saved us countless hours in managing files, edits and even major updates at the last minute for very complex submissions. We can’t live without using the platform now.

John Landsdown

John Landsdown

Director of Quality, Regulatory Affairs & Compliance

Quote Icon

We completed and successfully submitted our first FDA eSTAR submission using Essenvia. Thanks to this Platform our team was able to work together in one single place at any time to author, edit, and review the submission.

Marta Stepien

Marta Stepien

VP of Clinical, Regulatory and Quality Affairs

I’ve seen a lot of so-called AI softwares but very few are actually AI, and this [Essenvia] is the real deal.

Regulatory VP · Top 15 Medtech

Quote Icon

Essenvia RIM is easy to use and fast to setup. We save at least 20% of our time with using Essenvia's capabilities. Our experience with other RIMS tools made day-to-day operations more complex and did not fit into our workflows

Sejal Chitre

Sejal Chitre

Director Global Regulatory Affairs

Quote Icon

Essenvia greatly shortens the time to submission. It saved us countless hours in managing files, edits and even major updates at the last minute for very complex submissions. We can’t live without using the platform now.

John Landsdown

John Landsdown

Director of Quality, Regulatory Affairs & Compliance

Quote Icon

We completed and successfully submitted our first FDA eSTAR submission using Essenvia. Thanks to this Platform our team was able to work together in one single place at any time to author, edit, and review the submission.

Marta Stepien

Marta Stepien

VP of Clinical, Regulatory and Quality Affairs

See what your portfolio looks like when everything is sellable and audit-ready.

A 30-minute demo, on your products and your markets. No sandbox, no trial to configure a working conversation with people who know regulatory.

See what your portfolio looks like when everything is sellable and audit-ready.

A 30-minute demo, on your products and your markets. No sandbox, no trial to configure a working conversation with people who know regulatory.

See what your portfolio looks like when everything is sellable and audit-ready.

A 30-minute demo, on your products and your markets. No sandbox, no trial to configure a working conversation with people who know regulatory.